* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 10,000 tests per day.
Total Reported: 1,200,000+
With the onslaught of the Covid-19 pandemic, last year was an exceptional one for the healthcare industry. The outstanding work on the frontlines by doctors,
Ipsum sponsored and partnered with CORE (Community Organized Relief Effort) and with Cobb and Douglas Health Foundation to provide free fresh food boxes to assist seniors and families in need. Ipsum employees volunteered to help deliver the boxes.
This study was conducted with the CDC, Atlanta, COVID-19 Response Team, Epidemic Intelligence Service, Georgia Department of Public Health and Ipsum Diagnostics processed all the
Lauren Spanjer Bricks is co-founder and chief operations officer of Ipsum Diagnostics, an independent clinical and anatomical testing laboratory that received emergency use authorization from the
Ipsum Diagnostics lab in north Fulton County processes thousands of coronavirus tests every day.